The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Metformin – a Future Therapy for Neurodegenerative Diseases: Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla
Open accessAbstract
Type 2 diabetes mellitus (T2DM) is a complex, chronic and progressive metabolic disease, which is characterized by relative insulin deficiency, insulin resistance, and high glucose levels in blood. Esteemed published articles and epidemiological data exhibit an increased risk of developing Alzheimer's disease (AD) in diabetic pateints. Metformin is the most frequently used oral anti-diabetic drug, which apart from hypoglycaemic activity, improves serum lipid profiles, positively influences the process of haemostasis, and possesses anti-inflammatory properties. Recently, scientists have put their efforts in establishing metformin's role in the treatment of neurodegenerative diseases, such as AD, amnestic mild cognitive impairment and Parkinson's disease. Results of several clinical studies confirm that long term use of metformin in diabetic patients contributes to better cognitive function, compared to participants using other anti-diabetic drugs. The exact mechanism of metformin's advantageous activity in AD is not fully understood, but scientists claim that activation of AMPK-dependent pathways in human neural stem cells might be responsible for the neuroprotective activity of metformin. Metformin was also found to markedly decease Beta-secretase 1 (BACE1) protein expression and activity in cell culture models and in vivo, thereby reducing BACE1 cleavage products and the production of Aβ (β-amyloid). Furthermore, there is also some evidence that metformin decreases the activity of acetylcholinesterase (AChE), which is responsible for the degradation of acetylcholine (Ach), a neurotransmitter involved in the process of learning and memory. In regard to the beneficial effects of metformin, its anti-inflammatory and anti-oxidative properties cannot be omitted. Numerous in vitro and in vivo studies have confirmed that metformin ameliorates oxidative damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Clinical pharmacokinetics of metformin
Graham, G. G., Punt, J., Arora, M., Day, R. O., Doogue, M. P., Duong, J. K., Furlong, T. J., Greenfield, J. R., Greenup, L. C., Kirkpatrick, C. M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11534750-000000000-00000 · Cited by 1,318
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function
Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.661 · Cited by 1,258 · cited 1×
“other studies indicating an elevated risk of developing AD in patients suffering from T2DM (28,29).”
BackgroundType 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress
Rolo, A. P., & Palmeira, C. M. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.003 · Cited by 1,007
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
Greig, N. H., Utsuki, T., Ingram, D. K., Wang, Y., Pepeu, G., Scali, C., Yu, Q.-S., Mamczarz, J., Holloway, H. W., Giordano, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508575102 · Cited by 734
Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 714
APOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASE
Roses, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.387 · Cited by 707 · cited 1×
“Since 1996 it has been confirmed that homozygous ApoE-ε4 are responsible for increasing the risk of AD by eight folds in Caucasians (35).”
BackgroundHyperinsulinemia and risk of Alzheimer disease
Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683
Chen, Z., & Zhong, C. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.004 · Cited by 673
Tau phosphorylation in neuronal cell function and dysfunction
Johnson, G. V. W., & Stoothoff, W. H. (2004) · Journal of Cell Science · doi:10.1242/jcs.01558 · Cited by 624
Is Alzheimer’s disease a type 3 diabetes? A critical appraisal
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621
Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M., & Selkoe, D. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103754 · Cited by 619
Luca, S., Yau, W.-M., Leapman, R., & Tycko, R. (2007) · Biochemistry · doi:10.1021/bi701427q · Cited by 578
Insulin in the brain: There and back again
Banks, W. A., Owen, J. B., & Erickson, M. A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.006 · Cited by 574
Clark, A., Wells, C. A., BULEY, I. D., Cruickshank, J. K., Vanhegan, R. I., Matthews, D. R., Cooper, G. J. S., Holman, R. R., & Turner, R. C. (1988) · PubMed · Cited by 518
Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells
Isoda, K., Young, J. L., Zirlik, A., MacFarlane, L. A., Tsuboi, N., Gerdes, N., Schönbeck, U., & Libby, P. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000201938.78044.75 · Cited by 499
A High Plasma Concentration of TNF- Is Associated With Dementia in Centenarians
Bruunsgaard, H., Andersen-Ranberg, K., Jeune, B., Pedersen, A. N., Skinhoj, P., & Pedersen, B. K. (1999) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/54.7.m357 · Cited by 459
Łabuzek, K., Suchy, D., Gabryel, B., Bielecka, A., Liber, S., & Okopień, B. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70357-1 · Cited by 404
Butterfield, D. A., Di Domenico, F., & Barone, E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.010 · Cited by 402
Chen, Y., Zhou, K., Wang, R., Liu, Y., Kwak, Y.-D., Ma, T., Thompson, R. C., Zhao, Y., Smith, L., Gasparini, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807991106 · Cited by 390
Imfeld, P., Bodmer, M., Jick, S. S., & Meier, C. R. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03916.x · Cited by 388
Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377
An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer’s disease
Zhang, J., Chen, C., Hua, S., Liao, H., Wang, M., Xiong, Y., & Cao, F. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.024 · Cited by 376
Increased risk of cognitive impairment in patients with diabetes is associated with metformin
Moore, E. M., Mander, A. G., Ames, D., Kotowicz, M. A., Carne, R. P., Brodaty, H., Woodward, M., Boundy, K., Ellis, K. A., Bush, A. I., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0229 · Cited by 349
Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
Ng, T. P., Feng, L., Yap, K. B., Lee, T. S., Tan, C. H., & Winblad, B. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131901 · Cited by 334
Metformin therapy and clinical uses
Scarpello, J. H., & Howlett, H. C. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.027 · Cited by 318 · cited 1×
“Therefore, it contributes to the observed elevation in mitochondrial functions (71).”
BackgroundType 3 diabetes is sporadic Alzheimer׳s disease: Mini-review
de la Monte, S. M. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.06.008 · Cited by 313
Gupta, A., Bisht, B., & Dey, C. S. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.033 · Cited by 302
García-Ayllón, M.-S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00022 · Cited by 299
The role of type 2 diabetes in neurodegeneration
Verdile, G., Fuller, S. J., & Martins, R. N. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.008 · Cited by 272
Reducing insulin resistance with metformin: the evidence today
Giannarelli, R., Aragona, M., Coppelli, A., & Del Prato, S. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72785-2 · Cited by 269
Metformin attenuates Alzheimer’s disease-like neuropathology in obese, leptin-resistant mice
Li, J., Deng, J., Sheng, W., & Zuo, Z. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.002 · Cited by 260
Sultana, R., Boyd-Kimball, D., Poon, H. F., Cai, J., Pierce, W. M., Klein, J. B., Markesbery, W. R., Zhou, X. Z., Lu, K. P., & Butterfield, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.005 · Cited by 253
Reddy, P. H., Manczak, M., Mao, P., Calkins, M. J., Reddy, A. P., & Shirendeb, U. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100504 · Cited by 240
Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology
Abner, E. L., Nelson, P. T., Kryscio, R. J., Schmitt, F. A., Fardo, D. W., Woltjer, R. L., Cairns, N. J., Yu, L., Dodge, H. H., Xiong, C., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.006 · Cited by 233
Guo, M., Mi, J., Jiang, Q., Xu, J., Tang, Y., Tian, G., & Wang, B. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12265 · Cited by 225
Risk of Incident Alzheimer's Disease in Diabetic Patients: A Systematic Review of Prospective Trials
Kopf, D., & Frölich, L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1011 · Cited by 223
Different Patterns of Cerebral Injury in Dementia With or Without Diabetes
Sonnen, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.579 · Cited by 223
The aggregation potential of human amylin determines its cytotoxicity towards islet β‐cells
Konarkowska, B., Aitken, J. F., Kistler, J., Zhang, S., & Cooper, G. J. S. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05367.x · Cited by 219
Chakraborty, A., Chowdhury, S., & Bhattacharyya, M. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.11.030 · Cited by 216
Esteghamati, A., Eskandari, D., Mirmiranpour, H., Noshad, S., Mousavizadeh, M., Hedayati, M., & Nakhjavani, M. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2012.08.006 · Cited by 212
Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice
Oliveira, W. H., Nunes, A. K., França, M. E. R., Santos, L. A., Lós, D. B., Rocha, S. W., Barbosa, K. P., Rodrigues, G. B., & Peixoto, C. A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.013 · Cited by 209
Bhutada, P., Mundhada, Y., Bansod, K., Tawari, S., Patil, S., Dixit, P., Umathe, S., & Mundhada, D. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.022 · Cited by 205
Differential accumulation of advanced glycation end products in the course of diabetic retinopathy
Hammes, H.-P., Alt, A., Niwa, T., Clausen, J. T., Bretzel, R. G., Brownlee, M., & Schleicher, E. D. (1999) · Diabetologia · doi:10.1007/s001250051221 · Cited by 205
Metformin Decreases Intracellular Production of Reactive Oxygen Species in Aortic Endothelial Cells
Ouslimani, N., Peynet, J., Bonnefont-Rousselot, D., Thérond, P., Legrand, A., & Beaudeux, J.-L. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.029 · Cited by 204
Inflammatory changes parallel the early stages of Alzheimer disease
Parachikova, A., Agadjanyan, M. G., Cribbs, D. H., Blurton-Jones, M., Perreau, V., Rogers, J., Beach, T. G., & Cotman, C. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.014 · Cited by 203
Molecular links between Alzheimer’s disease and diabetes mellitus
Yang, Y., & Song, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.009 · Cited by 201
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype
Gibson, G. E., Haroutunian, V. H., Zhang, H., Park, L. C. H., Shi, Q., LESSER, M. L., Mohs, R. C., Sheu, R., & Blass, J. P. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200009)48:3<297::aid-ana3>3.0.co;2-z · Cited by 198
An update on type 2 diabetes, vascular dementia and Alzheimer’s disease.
Exalto, L. G., Whitmer, R. A., Kappele, L. J., & Biessels, G. J. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.07.014 · Cited by 194
Setter, S. M., Iltz, J. L., Thams, J., & Campbell, R. K. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90089-0 · Cited by 191
Metabolic Regulation of Neuronal Plasticity by the Energy Sensor AMPK
Potter, W. B., O'Riordan, K. J., Barnett, D., Osting, S. M. K., Wagoner, M., Burger, C., & Roopra, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008996 · Cited by 189
Type 2 Diabetes Is Negatively Associated With Alzheimer's Disease Neuropathology
Beeri, M. S., Silverman, J. M., Davis, K. L., Marin, D., Grossman, H. Z., Schmeidler, J., Purohit, D. P., Perl, D. P., Davidson, M., Mohs, R. C., et al. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.4.471 · Cited by 188
Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes
Calabrese, V., Cornelius, C., Leso, V., Trovato-Salinaro, A., Ventimiglia, B., Cavallaro, M., Scuto, M., Rizza, S., Zanoli, L., Neri, S., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.003 · Cited by 177
Apelt, J., Bigl, M., Wunderlich, P., & Schliebs, R. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.006 · Cited by 175
Review: Role of metformin in the management of polycystic ovary syndrome
Lashen, H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810380215 · Cited by 173
Rizos, C. V., & Elisaf, M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.02.038 · Cited by 168
Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice
Zhou, W., Kavelaars, A., & Heijnen, C. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151890 · Cited by 165
Bonnefont-Rousselot, D., Raji, B., Walrand, S., Gardès-Albert, M., Jore, D., Legrand, A., Peynet, J., & Vasson, M. P. (2003) · Metabolism · doi:10.1053/meta.2003.50093 · Cited by 162
Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
Emami Riedmaier, A., Fisel, P., Nies, A. T., Schaeffeler, E., & Schwab, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.11.005 · Cited by 161
Batchuluun, B., Inoguchi, T., Sonoda, N., Sasaki, S., Inoue, T., Fujimura, Y., Miura, D., & Takayanagi, R. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.10.025 · Cited by 161
Hanna, R. K., Zhou, C., Malloy, K., Sun, L., Zhong, Y., Gehrig, P. A., & Bae-Jump, V. L. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.01.009 · Cited by 160
Diabetes drugs and neurological disorders: new views and therapeutic possibilities
Patrone, C., Eriksson, O., & Lindholm, D. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70125-6 · Cited by 160
Increased Insulin Secretion and Glucose Tolerance in Mice Lacking Islet Amyloid Polypeptide (Amylin)
Gebre-Medhin, S., Mulder, H., Pekny, M., Westermark, G., Törnell, J., Westermark, P., Sundler, F., Ahrén, B., & Betsholtz, C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9308 · Cited by 157 · cited 1×
“The exact functions of hIAPP are still unknown; however, studies conducted onmice models showed that the absence of hIAPP enhanced insulin secretion and improved glucose tolerance (67).”
BackgroundChen, F., Dong, R. R., Zhong, K. L., Ghosh, A., Tang, S. S., Long, Y., Hu, M. Y., Miao, M. X., Liao, J. M., Sun, H. B., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.023 · Cited by 148
Chiang, M., Cheng, Y., Chen, S., Yen, C., & Huang, R. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.08.013 · Cited by 131
Zhao, R., Xu, X., Xu, F., Zhang, W.-L., Zhang, W.-L., Liu, L.-M., & Wang, W. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.130 · Cited by 125
Ma, J., Yu, H., Liu, J., Chen, Y., Wang, Q., & Xiang, L. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.010 · Cited by 124
In vivo imaging of neuroinflammation
Cagnin, A., Gerhard, A., & Banati, R. B. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00107-4 · Cited by 121
Bułdak, Ł., Łabuzek, K., Bułdak, R. J., Kozłowski, M., Machnik, G., Liber, S., Suchy, D., Duława, A., & Okopień, B. (2014) · Pharmacological Reports · doi:10.1016/j.pharep.2013.11.008 · Cited by 120
Increased Glucose Transport into Neurons Rescues Aβ Toxicity in Drosophila
Niccoli, T., Cabecinha, M., Tillmann, A., Kerr, F., Wong, C. T., Cardenes, D., Vincent, A. J., Bettedi, L., Li, L., Grönke, S., et al. (2016) · Current Biology · doi:10.1016/j.cub.2016.07.017 · Cited by 120
Picone, P., Nuzzo, D., Caruana, L., Messina, E., Barera, A., Vasto, S., & Carlo, M. D. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.01.017 · Cited by 118
Wang, C., Liu, C., Gao, K., Zhao, H., Zhou, Z., Shen, Z., Guo, Y., Li, Z., Yao, T., & Mei, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.148 · Cited by 110
Differential metformin dose-dependent effects on cognition in rats: role of Akt
Mostafa, D. K., Ismail, C. A., & Ghareeb, D. A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4301-2 · Cited by 107
Regulation of β‐site APP‐cleaving enzyme 1 gene expression and its role in Alzheimer’s Disease
Sun, X., Bromley‐Brits, K., & Song, W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07515.x · Cited by 105
Abbott, C. A., Mackness, M., Kumar, S., Olukoga, A. O., Gordon, C., Arrol, S., Bhatnagar, D., Boulton, A. J. M., & Durrington, P. N. (1993) · Clinical Science · doi:10.1042/cs0850077 · Cited by 96
Oxidative injury and neuropathy in diabetes and impaired glucose tolerance
Russell, J. W., Berent‐Spillson, A., Vincent, A. M., Freimann, C. L., Sullivan, K. A., & Feldman, E. L. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.013 · Cited by 92
Asadbegi, M., Yaghmaei, P., Salehi, I., Ebrahim‐Habibi, A., & Komaki, A. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.02.005 · Cited by 92
バトチュルーン, バ. (2014) · Atherosclerosis · doi:10.15017/1470539 · Cited by 92
McNeilly, A. D., Williamson, R., Balfour, D. J. K., Stewart, C. A., & Sutherland, C. D. (2012) · Diabetologia · doi:10.1007/s00125-012-2686-y · Cited by 90
Allard, J. S., Perez, E. J., Fukui, K., Carpenter, P., Ingram, D. K., & Cabo, R. D. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.012 · Cited by 88
Metformin: The hidden chronicles of a magic drug
Mahmood, K., Naeem, M., & Rahimnajjad, N. A. (2012) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.10.011 · Cited by 87
Chung, M.-M., Chen, Y., Pei, D., Cheng, Y., Sun, B., Nicol, C. J. B., Yen, C., Chen, H., Liang, Y., & Chiang, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.006 · Cited by 86
The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study
Herath, P. M., Cherbuin, N., Eramudugolla, R., & Anstey, K. J. (2016) · BioMed Research International · doi:10.1155/2016/7208429 · Cited by 85
Acetylcholinesterase: structure and use as a model for specific cation—protein interactions
Sussman, J. L., & Silman, I. (1992) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(92)90207-n · Cited by 84
Lennox, R., Porter, D. W., Flatt, P. R., Hölscher, C., Irwin, N., & Gault, V. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.06.026 · Cited by 82
Metformin sensitizes endometrial cancer cells to chemotherapy by repressing glyoxalase I expression
Dong, L., Zhou, Q., Zhang, Z., Zhu, Y., Duan, T., & Feng, Y. (2012) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2011.01839.x · Cited by 79
The Anti-Diabetic Drug Metformin Reduces BACE1 Protein Level by Interfering with the MID1 Complex
Hettich, M. M., Matthes, F., Ryan, D. P., Griesche, N., Schröder, S., Dorn, S., Krauß, S., & Ehninger, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102420 · Cited by 78
Mima, Y., Kuwashiro, T., Yasaka, M., Tsurusaki, Y., Nakamura, A., Wakugawa, Y., & Okada, Y. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.10.016 · Cited by 75
Moon, J. S., Karunakaran, U., Elumalai, S., Lee, I., Lee, H. W., Kim, Y., & Won, K. C. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.09.001 · Cited by 75
Cerebral Microvascular Lesions on High-Resolution 7-Tesla MRI in Patients With Type 2 Diabetes
Brundel, M., Reijmer, Y. D., van Veluw, S. J., Kuijf, H. J., Luijten, P. R., Kappelle, L. J., Biessels, G. J., & on behalf of the Utrecht Vascular Cognitive Impairment (VCI) Study Group (2014) · Diabetes · doi:10.2337/db14-0122 · Cited by 72
Li, J., Cesari, M., Liu, F., Dong, B., & Vellas, B. J. (2016) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.07.003 · Cited by 70
Alzoubi, K. H., Khabour, O. F., Al-Azzam, S. I., Tashtoush, M., & Mhaidat, N. M. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120223201 · Cited by 65
Involvement of catalase in the protective benefits of metformin in mice with oxidative liver injury
Dai, J., Liu, M., Ai, Q., Lin, L., Wu, K., Deng, X., Jing, Y., Jia, M., Wan, J., & Zhang, L. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.03.013 · Cited by 64
Picone, P., Vilasi, S., Librizzi, F., Contardi, M., Nuzzo, D., Caruana, L., Baldassano, S., Amato, A., Mulè, F., Biagio, P. L. S., et al. (2016) · Aging · doi:10.18632/aging.101004 · Cited by 64
Huttunen, K. M., Mannila, A., Laine, K., Kemppainen, E. K., Leppänen, J., Vepsäläinen, J., Järvinen, T., & Rautio, J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900274q · Cited by 63
Self-citationHuttunen, K. M., Rautio, J., Leppänen, J., Vepsäläinen, J., & Keski‐Rahkonen, P. (2009) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2009.04.033 · Cited by 56
Self-citationImramovský, A., Štěpánková, Š., Vančo, J., Pauk, K., Férriz, J. M., Vinšová, J., & Jampílek, J. (2012) · Molecules · doi:10.3390/molecules170910142 · Cited by 55
Regulation of mitochondrial dynamics and neurodegenerative diseases.
Han, X.-J., Tomizawa, K., Fujimura, A., Ohmori, I., Nishiki, T., Matsushita, M., & Matsui, H. (2011) · PubMed · doi:10.18926/amo/43824 · Cited by 51
Mirmiranpour, H., Mousavizadeh, M., Noshad, S., Ghavami, M., Ebadi, M., Ghasemiesfe, M., Nakhjavani, M., & Esteghamati, A. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.05.006 · Cited by 51
Domínguez, R. O., Pagano, M. A., Marschoff, E., González, S., Repetto, M. G., & Serra, J. A. (2013) · Neurología · doi:10.1016/j.nrl.2013.05.006 · Cited by 48
Mendelsohn, A. R., & Larrick, J. W. (2011) · Rejuvenation Research · doi:10.1089/rej.2011.1238 · Cited by 45
Ascher‐Svanum, H., Chen, Y.-F., Hake, A. M., Kahle‐Wrobleski, K., Schuster, D., Kendall, D. M., & Heine, R. J. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.01.002 · Cited by 45
Baviera, M., Monesi, L., Marzona, I., Avanzini, F., Monesi, G., Nobili, A., Tettamanti, M., Riva, E., Cortesi, L., Bortolotti, A., et al. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.05.004 · Cited by 44
Novel therapeutic targets of metformin: metabolic syndrome and cardiovascular disease
Ladeiras‐Lopes, R., Fontes‐Carvalho, R., Bettencourt, N., Sampaio, F., Gama, V., & Leite-Moreira, A. F. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1025051 · Cited by 44
Acetylcholinesterase: Structure and use as a model for specific cation-protein interactions
Sussman, J. L., & Silman, I. (1992) · Current Biology · doi:10.1016/0960-9822(92)90176-b · Cited by 44
Gómez‐Ramos, P., Bouras, C., & Mora´n, M. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)91852-x · Cited by 42
Vaisi‐Raygani, A., Zahrai, M., Soltanzadeh, A., Doosti, M., Javadi, E., & Pourmotabbed, T. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.08.057 · Cited by 41
Domínguez, R. O., Pagano, M. A., Marschoff, E., González, S., Repetto, M. G., & Serra, J. A. (2014) · Neurología (English Edition) · doi:10.1016/j.nrleng.2014.10.001 · Cited by 38
Khallaghi, B., Safarian, F., Nasoohi, S., Ahmadiani, A., & Dargahi, L. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.024 · Cited by 38
Metformin prevents cerebellar granule neurons against glutamate-induced neurotoxicity
Zhou, C., Sun, R., Zhuang, S., Sun, C., Jiang, Y., Cui, Y., Li, S., Xiao, Y., Du, Y., Gu, H., et al. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.02.009 · Cited by 38
Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach
Sridhar, G. R., Nirmala, G., Apparao, A., Madhavi, A., Sreelatha, S., Rani, J. S., & Vijayalakshmi, P. (2005) · Lipids in Health and Disease · doi:10.1186/1476-511x-4-18 · Cited by 37
Effect of canagliflozin and metformin on cortical neurotransmitters in a diabetic rat model
Arafa, N. M. S., Marie, M.-A. S., & AlAzimi, S. A. M. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.08.016 · Cited by 36
Mazzaglia, G., Yurgin, N., Boye, K. S., Trifirò, G., Cottrell, S., Allen, E., Filippi, A., Medea, G., & Cricelli, C. A. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.03.009 · Cited by 35
Saliu, J. A., Oboh, G., Omojokun, O. S., da Rocha, J. B. T., Schetinger, M. R. C., Guterries, J., Stefanello, N., Carvalho, F. B., Schmatz, R., Morsch, V. M., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.10.043 · Cited by 33
Arendt, T., & Brückner, M. K. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90805-h · Cited by 32
Moore, E., Mander, A. G., Ames, D. J., Kotowicz, M. A., Carne, R., Brodaty, H., Woodward, M., Boundy, K., Ellis, K. A., Bush, A. I., et al. (2013) · Diabetes Care · doi:10.2337/dc13-er11b · Cited by 29
Is Metformin-Induced Vitamin B12 Deficiency Responsible for Cognitive Decline in Type 2 Diabetes?
Khattar, D., Khaliq, F., Vaney, N., & Madhu, S. V. (2016) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.185952 · Cited by 28
Glutathione-S-transferase selective release of metformin from its sulfonamide prodrug
Rautio, J., Vernerová, M., Aufderhaar, I., & Huttunen, K. M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.09.019 · Cited by 27
Self-citationConvenient microwave-assisted synthesis of lipophilic sulfenamide prodrugs of metformin
Huttunen, K. M., Leppänen, J., Laine, K., Vepsäläinen, J., & Rautio, J. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.023 · Cited by 27
Self-citationZhang, Z., Fang, P., Shi, M., Zhu, Y. N., & Bo, P. (2015) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2015.08.001 · Cited by 11
Effect of metformin on the spatial memory in aged rats
Ashrostaghi, Z., Ganji, F., & Sepehri, H. (2015) · National Journal of Physiology Pharmacy and Pharmacology · doi:10.5455/njppp.2015.5.1208201564 · Cited by 9
Old Drug Acquires New Target: Metformin and Sirt1
Bashmakov, Y. K., & Petyaev, I. M. (2011) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000107e · Cited by 9
Cited by
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632
Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
Twarowski, B., & Herbet, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076518 · Cited by 412
Xian, H., Liu, Y., Rundberg Nilsson, A., Gatchalian, R., Crother, T. R., Tourtellotte, W. G., Zhang, Y., Aleman-Muench, G. R., Lewis, G., Chen, W., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.004 · Cited by 407
Mitochondria as central regulators of neural stem cell fate and cognitive function
Khacho, M., Harris, R., & Slack, R. S. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0091-3 · Cited by 399
Diabetes drugs in the fight against Alzheimer's disease
Boccardi, V., Murasecco, I., & Mecocci, P. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100936 · Cited by 142
Metadata
- Authors
- Markowicz-Piasecka, M., Sikora, J., Szydłowska, A., Skupień, A., Mikiciuk-Olasik, E., & Huttunen, K. M.
- Venue
- Pharmaceutical Research
- Published
- 2017-06-06
- Volume
- 34
- Issue
- 12
- Pages
- 2614-2627
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2623583708
- Cited by
- 257
- References
- 132
- FWCI
- 17.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.